trial · primary record
Atezolizumab
Metastatic Colorectal Adenocarcinoma
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 120 |
| Primary completion | 2027-06-01 |
| Primary endpoint | Progression free survival (PFS) |
| Registry ID | NCT02997228 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:34.562Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02997228
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.